Novocure
Manufacturing · Switzerland · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Neuhofstrasse 21, Baar, Zug, 6340, Switz...Phone Number
+44 1534756700Website
www.novocure.comRevenue
$674.4 MillionStock Symbol
NVCRIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer and ovarian cancer. Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel.Explore more
Novocure Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Novocure your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Novocure has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Novocure recently announced quarterly report
Funding: Get notified immidiatlly once Novocure has new funding data
Product Launch: Get notified when Novocure launches new products
Congratulate Masked Content for being promoted to Masked Content at Novocure
Click to see if Novocure had a recent Job posting/layoffs
Check out if Novocure is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Novocure, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Novocure as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Novocure is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Novocure is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Novocure.
Novocure financials insights
Gather financial insights about Novocure, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$158M
2018
Debt
$150M
2024
Debt
$400M
Novocure Tech Stack
A closer look at the technologies used by Novocure
See more technologies
Most Recent Scoops
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Person-Based
Earnings, Medical Research, Pharmaceuticals, Finance
Open Position
Novocure News & Media
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026?
AI-powered diagnostics meet global oncology innovation as two medical disruptors post strong revenue growth, yet face distinct risk and valuation profiles.NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026?
Both companies target serious health challenges, but their financials and risk profiles reveal sharply different paths for growth-focused investors.Novocure Limited Investigation Initiated: SueWallSt Investigates the Officers and Directors of Novocure Limited (NVCR)
Novocure reported its Phase 3 TRIDENT Trial failed to achieve its primary endpoint of an increase in overall survival for patients at the start of chemoradiation. Shares were down more than 18% midday on June 18, 2026. NEW YORK,, June 18, 2026 /PRNewswire/ -- Investors who held Novocure...End Brain Cancer Initiative Releases Free Brain Cancer Education Videos Featuring GBM/rGBM Treatment Options/Research
Free patient education videos about GBM/rGBM brain cancer treatment options and research are now available to the public. SEATTLE, WA, UNITED STATES, June 16, 2026 /EINPresswire.com/ -- On May 15, 2026, the End Brain Cancer Initiative (EBCI) produced …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Novocure
Sign Up For FreeTo access detailed company insights
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for... Read More
